News

Keeping you current on new and follow-on investments, portfolio product and service milestones, publications and events, management and board transitions, and other developments in Tullis funds.

April

8

TriSalus Life Sciences and MD Anderson Announce Strategic Research Collaboration to Evaluate Treatment of Solid Tumors

Studies to evaluate liver and pancreatic cancers with SD-101, an investigational TLR9 agonist, in...

8

ATEC Announces Preliminary First Quarter 2021 Revenue Results and Provides Corporate Updates

First quarter 2021 U.S. revenue grows approximately 50% compared to last year Full-year 2021...

8

electroCore Announces Top Line Results from SAVIOR-1 Study of Non-Invasive Vagus Nerve Stimulation (nVNS) in Hospitalized COVID-19 Patients

nVNS Decreases Certain Biomarkers Associated with the Severity of COVID-19 through Five Days of...

5

electroCore, Inc. Announces Regulatory Approval in Canada

gammaCore Sapphire products approved for prevention and therapeutic treatment of migraine and cluster headache...

29

Exagen Inc. Announces Study on the Long-Term Effects of COVID-19 Infection in the Development of Autoimmune Diseases

Collaboration with Emory University will utilize the AVISE® testing portfolio SAN DIEGO, March 29, 2021 (GLOBE...

29

neurolens Announces the nMD2

80% smaller than the first-generation nMD, and its diagnostic test is 35% faster Coppell,...

25

Exagen Inc. Announces Closing of Public Offering of Common Stock, Including Full Exercise of Underwriters’ Option to Purchase Additional Shares

Gross proceeds approximately $69.1 million before underwriting discounts and commissions and other offering expenses...

23

ATEC Announces Memphis Distribution Facility

Centralized distribution will ensure predictable surgical support as growth expands CARLSBAD, Calif., March 23,...

23

electroCore, Inc. Announces Exclusive Distribution Agreement with Silvert Medical Nv-Sa. For Western Europe

Silvert Medical will serve as exclusive distributor of gammaCore Sapphire™ in Belgium, Luxembourg, the Netherlands, and France...

22

Exagen Inc. Announces Pricing of Public Offering of Common Stock

Offering 3.7 million shares of common stock at $16.25/share SAN DIEGO, March 22, 2021 (GLOBE NEWSWIRE)...

16

Exagen Inc. Reports Fourth Quarter and Full Year 2020 Results

Quarterly Records: Revenue, Gross Margin, AVISE® CTD Volumes, and Adopters SAN DIEGO, March 16, 2021 (GLOBE...

15

ATEC Furthers Clinical Distinction with Launch of InVictus® OCT Posterior Fixation System for the Cervical and Thoracic Spine

Completes InVictus System Allowing Seamless Spinal Fixation from Occiput to Ilium CARLSBAD, Calif., March...